Whole body functional MR imaging: hemato-oncologic applications

被引:5
|
作者
Luciani, A. [1 ]
Lin, C. [1 ]
Beaussart, P. [1 ]
Zerbib, P. [1 ]
Haioun, C. [2 ]
Rahmouni, A. [1 ]
机构
[1] Grp Hosp Henri Mondor Chenevier, AP HP, Serv Imagerie Med, Fac Med Paris 12, F-94010 Creteil, France
[2] Grp Hosp Henri Mondor Chenevier, AP HP, Serv Hematol, Fac Med Paris 12, F-94010 Creteil, France
来源
JOURNAL DE RADIOLOGIE | 2010年 / 91卷 / 03期
关键词
MRI; Functional MRI; Myeloma; Lymphoma; Diffusion; Contrast agent; BONE-MARROW ANGIOGENESIS; SUV-BASED ASSESSMENT; TURBO SPIN-ECHO; B-CELL LYMPHOMA; MULTIPLE-MYELOMA; PROGNOSTIC VALUE; SINGLE-SHOT; INITIAL-EXPERIENCE; STAGING SYSTEM; F-18-FDG PET;
D O I
10.1016/S0221-0363(10)70053-6
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Hemato-oncologic imaging combines anatomical and functional imaging data for optimal staging and follow-up of patients. It is currently possible to achieve high spatial resolution and functional evaluation at whole body MR imaging. Functional imaging may be achieved with two techniques: dynamic imaging following intravenous contrast injection and diffusion-weighted imaging. The purpose of this article is to demonstrate how both functional imaging techniques can be combined with whole body MR imaging for the evaluation of multiple myeloma and lymphomas.
引用
收藏
页码:375 / 380
页数:6
相关论文
共 50 条
  • [21] Evaluation of Asymptomatic Covid Infection in Children with Pediatric Hemato-Oncologic Disease
    Aysenur Bahadir
    Esra Özkaya
    Erol Erduran
    İlknur Tosun
    Gökçe Pinar Reis
    Gülay Kaya
    Indian Journal of Hematology and Blood Transfusion, 2023, 39 : 340 - 343
  • [22] Clinical consequences of imatinib plasma concentrations variability in hemato-oncologic patients
    Widmer, Nicolas
    Leyvraz, Serge
    Duchosal, Michel A.
    Rosselet, Anne
    Csajka, Chantal
    Henry, Hugues
    Debiec-Rychter, Maria
    Eap, Chin B.
    Biollaz, Jerome
    Buclin, Thierry
    Decosterd, Laurent A.
    THERAPEUTIC DRUG MONITORING, 2007, 29 (04) : 481 - 481
  • [23] Whole-Body MR Imaging: Musculoskeletal Applications
    Lecouvet, Frederic E.
    RADIOLOGY, 2016, 279 (02) : 345 - 365
  • [24] [Translated article] Medication reconciliation in pediatric hemato-oncologic patients: A multicenter study
    Vendrell, Margarita Cuervas-mons
    Fuentes, Dolores Pilar Iturgoyen
    Flaque, Miquel Villaronga
    Poy, Maria Jose Cabanas
    Fernandez-llamazares, Cecilia M.
    Del Vayo, Concha Alvarez
    Fernandez, Carmen Gallego
    Roca, Cristina Martinez
    Gago, Yolanda Hernandez
    Robles, Ana Garcia
    Corro, Beatriz Garrido
    FARMACIA HOSPITALARIA, 2023, 47 (06) : T261 - T267
  • [25] IFISTRATEGY: Spanish National Survey of Invasive Fungal Infection in Hemato-Oncologic Patients
    Vallejo, Carlos
    Jarque, Isidro
    Fortun, Jesus
    Casado, Araceli
    Peman, Javier
    JOURNAL OF FUNGI, 2023, 9 (06)
  • [26] THE SPECTRUM OF PARVOVIRUS B19 INFECTION IN A PEDIATRIC HEMATO-ONCOLOGIC WARD
    Lackner, Herwig
    Sovinz, Petra
    Benesch, Martin
    Aberle, Stephan W.
    Schwinger, Wolfgang
    Schmidt, Sandrin
    Strenger, Volker
    Pliemitscher, Sonja
    Urban, Christian
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2011, 30 (05) : 440 - 442
  • [27] Prevention of HBV Reactivation in Hemato-Oncologic Setting during COVID-19
    Sagnelli, Caterina
    Sica, Antonello
    Creta, Massimiliano
    Borsetti, Alessandra
    Ciccozzi, Massimo
    Sagnelli, Evangelista
    PATHOGENS, 2022, 11 (05):
  • [28] Outcomes and impact of multidisciplinary team care on immunologic and hemato-oncologic pediatric patients
    Dominguez Estirado, Alicia
    Solis Garcia, Gonzalo
    Huerta Aragones, Jorge
    Garrido Colino, Carmen
    Seoane-Reula, Elena
    Mata Fernandez, Cristina
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2023, 51 (01) : 154 - 158
  • [29] Outcome of hemato-oncologic patients with and without stem cell transplantation in a medical ICU
    Bruennler, T.
    Mandraka, F.
    Zierhut, S.
    Siebig, S.
    Wrede, C.
    Klebl, F.
    Holler, E.
    Salzberger, B.
    Schoelmerich, J.
    Langgartner, J.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2007, 12 (08) : 323 - 330
  • [30] Is hyperlactatemia a useful screening marker of severe sepsis in hemato-oncologic malignant patients?
    S Park
    J Huh
    Intensive Care Medicine Experimental, 3 (Suppl 1)